133 Molesworth Street
PO Box 5013
Wellington 6140
New Zealand
T+64 4 496 2000
9 February 2023
Mr Wood
By email: [FYI request #21719 email]
Ref:
H2023019871
Tēnā koe Mr Wood
Transfer of your request for official information Thank you for your request under the Official Information Act 1982 (the Act) to Manatū Hauora
(the Ministry of Health) on 3 February 2023 for information relating to a study titled:
Adverse
Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNtech) in Aotearoa New
Zealand. You requested:
“The Ministry of Health funded a preprint study: 'Adverse events following the BNT162b2
mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand' It was published
as a pre-print in the Lancet on 20 January 2023 here:
https://scanmail.trustwave.com/?c=15517&d=mqHc40SSGqb5cO6yjE4SoyLfvLEL-
rE87v4eD0ND_g&u=https%3a%2f%2fpapers%2essrn%2ecom%2fsol3%2fpapers%2ecfm
%3fabstract%5fid%3d4329970 It has since been removed. Please disclose when it was unpublished and why, and
whether it will be published again (before or after peer-review).”
The requested information is more closely connected to the functions of the National
Immunisation Programme at Te Whatu Ora – Health New Zealand. For this reason, I have
decided to transfer your request to Te Whatu Ora under section 14(b)(ii) of the Act. You can
expect a response from Te Whatu Ora in due course.
Under section 28(3) of the Act, you have the right to ask the Ombudsman to review any
decisions made under this request. The Ombudsman may be contacted by email at:
[email address] or by calling 0800 802 602.
Nāku noa, na
Jan Torres
Acting Manager, OIA Services
Government and Executive Services | Te Pou Whakatere Kāwanatanga
COPY OF OIA REQUEST
From: Mr Wood <[FYI request #21719 email]>
Sent on: Friday, February 3, 2023 5:54:33 AM
To: OIA/LGOIMA requests at Ministry of Health <[Ministry of Health request email]>
Subject: Official Information request - Pfizer Covid-19 Vaccine study pre-print unpublished
Dear Ministry of Health,
The Ministry of Health funded a preprint study: 'Adverse events following the BNT162b2 mRNA
COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand' It was published as a pre-print
in the Lancet on 20 January 2023 here:
https://scanmail.trustwave.com/?c=15517&d=mqHc40SSGqb5cO6yjE4SoyLfvLEL-
rE87v4eD0ND_g&u=https%3a%2f%2fpapers%2essrn%2ecom%2fsol3%2fpapers%2ecfm%3fa
bstract%5fid%3d4329970
It has since been removed. Please disclose when it was unpublished and why, and whether it
will be published again (before or after peer-review).
Yours faithfully,
Mr Wood
Page 2 of 2